Celcuity (CELC) Change in Account Payables (2016 - 2025)
Celcuity's (CELC) quarterly Change in Account Payables came in at -$4.8 million in Q4 2025, down 2273.42% YoY from $222000.0 in Q4 2024, and down 8672.73% on a QoQ basis from -$55000.0 in Q3 2025.
Analysis
Celcuity (CELC) Change in Account Payables (2016 - 2025) Analysis & Trends
Celcuity (CELC) has 10 years of Change in Account Payables data on file, last reported at -$4.8 million in Q4 2025.
- Quarterly Change in Account Payables fell 2273.42% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 million (down 170.44% YoY) and the FY2025 annual result came in at -$3.0 million, down 170.44% from the prior year.
- Change in Account Payables slipped to -$4.8 million in Q4 2025, from -$55000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q3 2024 to a low of -$4.8 million in Q4 2025.
- A 5-year average of $304481.3 and a median of $301047.0 in 2021 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 19904.03% — and 2025, when it plunged 2273.42%.
- Tracing CELC's Change in Account Payables over 5 years: stood at -$247449.0 in 2021, then plunged by 92.4% to -$476096.0 in 2022, then fell by 26.3% to -$601309.0 in 2023, then soared by 136.92% to $222000.0 in 2024, then sank by 2273.42% to -$4.8 million in 2025.
- The last three Change in Account Payables figures came in at -$4.8 million (Q4 2025), -$55000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Celcuity | 5.25 Bn | 5.25 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4.83 Mn |
| Sep 30, 2025 | -55,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 945,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Dec 31, 2023 | -601,309.00 |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 429,636.00 |
| Mar 31, 2023 | -8,545.00 |
| Dec 31, 2022 | -476,096.00 |
| Sep 30, 2022 | 848,031.00 |
| Jun 30, 2022 | 192,054.00 |
| Mar 31, 2022 | 513,091.00 |
| Dec 31, 2021 | -247,449.00 |
| Sep 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 364,094.00 |
| Mar 31, 2021 | 73,924.00 |